Infectious - Medika Life

Approximately 15 percent of those with a COVID-19 infection will develop long COVID. Long COVID is prevalent and more common among females and older individuals.

Too Much of a Good Thing

Richard Hatzfeld - March 9, 2023

Antimicrobial resistance is not an American problem; it is a threat shared by every country

North Texas Obgyns Need to Know About Monoclonal Antibodies for Covid-19

Dr Jeff Livingston - August 28, 2021

Obgyn physicians and women's health providers must help pregnant people find access to monoclonal antibody therapy during the early stages of a Covid-19 infection to help prevent severe disease and death.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

CATEGORIES

An Expert Perspective from Algeria on Hexavalent Vaccine Adoption

The Hidden Cost of Global Conflict: Why Health Security Is the First Casualty

The Strait That Ships the World’s Vaccines

Of Measles and Midterms

LATEST

TRENDING

Bacterial Vaginosis; What to Do When Your Vagina Smells Bad

Syphilis. What you Need to Know About This Sexually Transmitted Infection

The Truth about Douching

Trichomoniasis: A Common Sexually Transmitted Infection (STI)

Pre-Exposure Prophylaxis (PrEP) for HIV Prevention

Hepatitis B

Getting Tested for HIV. What Women Need to Know.

HPV, Human Papillomavirus

Hepatitis E

Hepatitis D

EDITORS CHOICE

Global childhood vaccination remains resilient, but equity cracks are widening

Long COVID-19: What Doctors Want You to Know

Too Much of a Good Thing

North Texas Obgyns Need to Know About Monoclonal Antibodies for Covid-19

CONNECT WITH US ON SOCIAL MEDIA

Compliance

CORPORATE & MEDIA

Popular categories